- Home
- THC vs FMS Comparison
THC vs FMS Comparison
Compare THC & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THC
- FMS
- Stock Information
- Founded
- THC 1967
- FMS 1996
- Country
- THC United States
- FMS Germany
- Employees
- THC N/A
- FMS N/A
- Industry
- THC Hospital/Nursing Management
- FMS Misc Health and Biotechnology Services
- Sector
- THC Health Care
- FMS Health Care
- Exchange
- THC Nasdaq
- FMS Nasdaq
- Market Cap
- THC 15.7B
- FMS 15.0B
- IPO Year
- THC N/A
- FMS 1996
- Fundamental
- Price
- THC $204.72
- FMS $26.85
- Analyst Decision
- THC Buy
- FMS Sell
- Analyst Count
- THC 18
- FMS 2
- Target Price
- THC $201.00
- FMS $30.00
- AVG Volume (30 Days)
- THC 1.2M
- FMS 330.4K
- Earning Date
- THC 10-28-2025
- FMS 11-04-2025
- Dividend Yield
- THC N/A
- FMS 2.12%
- EPS Growth
- THC N/A
- FMS 23.39
- EPS
- THC 15.65
- FMS 2.62
- Revenue
- THC $20,683,000,000.00
- FMS $22,922,038,756.00
- Revenue This Year
- THC $3.29
- FMS $2.01
- Revenue Next Year
- THC $4.28
- FMS $3.11
- P/E Ratio
- THC $13.10
- FMS $20.32
- Revenue Growth
- THC N/A
- FMS 0.53
- 52 Week Low
- THC $109.82
- FMS $18.94
- 52 Week High
- THC $207.14
- FMS $30.46
- Technical
- Relative Strength Index (RSI)
- THC 65.63
- FMS 65.34
- Support Level
- THC $197.58
- FMS $26.52
- Resistance Level
- THC $205.99
- FMS $26.00
- Average True Range (ATR)
- THC 4.95
- FMS 0.31
- MACD
- THC 0.12
- FMS 0.15
- Stochastic Oscillator
- THC 88.48
- FMS 91.48
About THC Tenet Healthcare Corporation
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (47 as of December 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.